Cosmos Health Sees Q3 Sales $17.400M vs $20.886M Est

Benzinga Newsdesk www.benzinga.com Positive 60.9%

Neg 0% Neu 0% Pos 60.9%

Cosmos Health (NASDAQ:COSM) sees Q3 sales of $17.400 million vs $20.886 million analyst estimate.

Comments

No comments yet. Be the first!